All data are based on the daily closing price as of September 6, 2024
l
LegoChem Biosciences
141080.KQ
62.63 USD
-0.28
-0.45%
Overview
Last close
62.63 usd
Market cap
2.25B usd
52 week high
73.21 usd
52 week low
24.64 usd
Target price
73.66 usd
Valuation
P/E
N/A
Forward P/E
N/A
Price/Sales
39.2374
Price/Book Value
4.7849
Enterprise Value
1.83B usd
EV/Revenue
32.0937
EV/EBITDA
-31.9336
Key financials
Revenue TTM
56.99M usd
Gross Profit TTM
13.35M usd
EBITDA TTM
-36.28M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
739.33B usd
Net debt
N/A usd
About
LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was formerly known as LegoChem Biosciences, Inc. and changed its name to LigaChem Biosciences Inc. in April 2024. LigaChem Biosciences Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.